Practical Pediatric HematologyAnupam Sachdeva Evidence-based medicine is the need of the hour. Every pediatrician strives for perfection is his or her practice. These are exciting times for Pediatric Hematology and Oncology. Major advances during the past decade in the field have enhanced the understanding and significantly influenced the management and outcome of many of these chronic and fatal diseases affecting children. While opportunities to learn decrease after one leaves the medical school, science keeps evolving. Keeping this in mind, Indian Academy of Pediatrics (IAP) envisaged starting specialty training under its plan of action 2006. Such trainings keep professional and residents updated about newly launched technologies and other advancements. This book is well illustrated and has many pictures and diagrams for the quick understanding of readers. This will be of use not only to the postgraduates of pediatrics but also will be of immense use to a general pediatrician as a ready-reckoner to be kept on the desk. |
From inside the book
Results 1-5 of 85
Page xxi
... Dosing 158 Reversal and Antidote 158 Side Effects 159 Vitamin K Antagonists 159 Mechanism of Action 159 Monitoring 159 Adverse Effects 159 Reversal and Antidote 160 Antiplatelet Therapy 160 Thrombolytic Therapy 160 Dosing in ...
... Dosing 158 Reversal and Antidote 158 Side Effects 159 Vitamin K Antagonists 159 Mechanism of Action 159 Monitoring 159 Adverse Effects 159 Reversal and Antidote 160 Antiplatelet Therapy 160 Thrombolytic Therapy 160 Dosing in ...
Page 32
... dose EPO (750 u/kg/week) vs high dose EPO (1500 u/kg/week) courses were used in a European trail in babies from day 3 of life to 37 weeks of postconception (Birth weight <1000 g). There was no difference in the transfusion requirements ...
... dose EPO (750 u/kg/week) vs high dose EPO (1500 u/kg/week) courses were used in a European trail in babies from day 3 of life to 37 weeks of postconception (Birth weight <1000 g). There was no difference in the transfusion requirements ...
Page 33
... doses of vitamin E, vitamin B12, folate and Fe (when using EPO). After discharge from hospital, regular hematocrit ... dose erythropoietin in extremely low birth weight infants. J Pediatr. 1998;132:866. Ohls RK, Ehrenkranz RA, Lemons ...
... doses of vitamin E, vitamin B12, folate and Fe (when using EPO). After discharge from hospital, regular hematocrit ... dose erythropoietin in extremely low birth weight infants. J Pediatr. 1998;132:866. Ohls RK, Ehrenkranz RA, Lemons ...
Page 38
... dose of 2 mg/kg three times a day for 3 months. Vitamin B12 and folate should also be supplemented on discharge to ... dose of erythropoietin is 75-300 units/kg/ week subcutaneously for 4 weeks starting at 3-4 weeks of age. To prevent ...
... dose of 2 mg/kg three times a day for 3 months. Vitamin B12 and folate should also be supplemented on discharge to ... dose of erythropoietin is 75-300 units/kg/ week subcutaneously for 4 weeks starting at 3-4 weeks of age. To prevent ...
Page 46
You have reached your viewing limit for this book.
You have reached your viewing limit for this book.
Contents
Chapter21 | 156 |
Chapter22 | 165 |
Chapter23 | 178 |
Chapter24 | 181 |
Chapter25 | 199 |
Chapter26 | 208 |
Chapter27 | 232 |
Chapter28 | 247 |
Chapter09 | 69 |
Chapter10 | 75 |
Chapter11 | 85 |
Chapter12 | 90 |
Chapter13 | 97 |
Chapter14 | 115 |
Chapter15 | 120 |
Chapter16 | 125 |
Chapter17 | 130 |
Chapter18 | 144 |
Chapter19 | 148 |
Chapter20 | 153 |
Chapter29 | 259 |
Chapter30 | 262 |
Chapter31 | 266 |
Chapter32 | 272 |
Chapter33 | 281 |
Chapter34 | 289 |
Chapter35 | 298 |
Chapter36 | 305 |
Chapter37 | 309 |
Index | 313 |
Other editions - View all
Common terms and phrases
abnormalities acid activity acute adults antibodies anticoagulant antigen aplastic anemia APTT assay associated bleeding blood loss bone marrow transplantation catheter cause chemotherapy child childhood chronic clinical concentration congenital cytopenia decreased defects develop diagnosis disease disorders Disseminated intravascular coagulation donor dose drugs erythrocyte erythropoietin factor VIII ferritin fetal fibrin fibrinogen folate g/dl gene globin granulocytes Haematol hematocrit hematological hemoglobin hemolysis hemolytic anemia hemophilia hemorrhage heparin hepatitis immune increased India infants infection infusion inhibitor intravenous iron deficiency ischemic laboratory leukemia levels liver malignancy mutations myelodysplastic syndrome myeloid neonatal neutropenia newborn normal nutritional occur oral patients Pediatr peripheral plasma platelet platelet count platelet transfusion present preterm prophylaxis protein prothrombin red cell reticulocyte count risk serum severe splenectomy stem cell stroke studies syndrome Table thalassemia therapy thrombin thrombocytopenia thrombocytosis thrombosis tissue treatment usually venous viral virus vitamin